key: cord-1033080-pdo8jmmb
authors: Loschwitz, Jennifer; Jäckering, Anna; Keutmann, Monika; Olagunju, Maryam; Eberle, Raphael J.; Coronado, Monika Aparecida; Olubiyi, Olujide O.; Strodel, Birgit
title: Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay
date: 2021-03-29
journal: Bioorg Chem
DOI: 10.1016/j.bioorg.2021.104862
sha: 5a034c5d5c608dd5980dcdab3ff3a91f44f4ed33
doc_id: 1033080
cord_uid: pdo8jmmb

For the COVID-19 pandemic caused by SARS-CoV-2, there are currently no effective drugs or vaccines to treat this coronavirus infection. In this study, we focus on the main protease enzyme of SARS-CoV-2, 3CLpro, which is critical for viral replication. We employ explicit solvent molecular dynamics simulations of about 150 compounds docked into 3CLpro’s binding site and that had emerged as good main protease ligands from our previous in silico screening of over 1.2 million compounds. By incoporating protein dynamics and applying a range of structural descriptors, such as the ability to form specific contacts with the catalytic dyad residues of 3CLpro and the structural fluctuations of the ligands in the binding site, we are able to further refine our compound selection. Fourteen compounds including estradiol shown to be the most promising based on our calculations were procured and screened against recombinant 3CLpro in a fluorescence assay. Eight of these compounds have significant activity in inhibiting the SARS-CoV-2 main protease. Among these are corilagin, a gallotannin, and lurasidone, an antipsychotic drug, which emerged as the most promising natural product and drug, respectively, and might thus be candidates for drug repurposing for the treatment of COVID-19. In addition, we also tested the inhibitory activity of testosterone, and our results reveal testosterone as possessing moderate inhibitory potency against the 3CLpro enzyme, which may thus provide an explanation why older men are more severely affected by COVID-19.

Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay ⋆,⋆⋆ 16 COVID-19 infection begins with the exposure of a human 17 host to the recently discovered SARS-CoV-2, a positive-sense 18 RNA virus belonging to the coroviridae family. The first crit- 19 ical stage in the development of a COVID-19 diseased state 20 involves viral entry whereby the viral pathogen employs its 21 surface spike glycoprotein in binding to the host's angiotensin 22 converting enzyme 2 (ACE2) [1, 2, 3, 4] . Following invasion 23 of the host cells, the next critical stage that is central to a 

Computational design involving ligand docking protocols is a significant percentage of these publications. In our first were included because some of them were identified as good 117 binders by the initial study [6] . In consideration of the ob- Jin et al. [9] , and four recently identified 125 inhibitory -ketoamides [10] . In total, 160 compounds were 126 considered in this work, which are listed in Table S1 and for 127 which 20 ns MD simulations were performed. To progress 128 the predicted inhibitors to the next simulation phase, we em-129 ployed the following three selection criteria: 130 1. the root mean square deviation (RMSD) from the binding site, for which COM is plotted in Figure 2 . The interactions of the two ligands with the binding site were analyzed and plotted with LigPlot+ [12, 13] . Hydrogen bonds are indicated by yellow dashed lines between the atoms involved and the donor-acceptor distance is given in Å, while hydrophobic contacts are represented by gray arcs with spokes radiating towards the ligand atoms they contact. The contacted atoms are shown with spokes radiating back. (C) The RMSD ligand of estradiol (green) and 2-hydroxyestrone (red) is shown over simulation time. The cutoff value at 6 Å used to distinguish between good (e.g., estradiol) and poor (e.g., 2-hydroxyestrone) binders is marked as a gray dotted line. (D) The steroid scaffold is shown with functional moieties at the D ring of some of the steroids analyzed in this study highlighted: estradiol (R=a, green), 2-hydroxyestrone and androstenedione (R=b, red), estetrol (R=a plus hydroxy groups shown in light-blue), and allopregnanolone (R=c, blue product. Trailing closely behind these two are three drugs: can be seen in Figure S4 . (Table 2) . Here, residues interacting 527 with several ligands and those being involved in hydrogen 528 bonding are considered as more important for inhibition than 529 those not fulfilling these two criteria.

The catalytic dyad residues H41 and C145 form hydro-531 gen bonds exclusively with ZINC000011865175 but have 532 less strong interactions with the other inhibitors ( Figure S5 ).

While C145 Table 2 Binding site residues interacting with the top eight inhibitors. The number of ligands interacting with the different binding site residues via hydrogen bonds exclusively or via any kind of interactions (including hydrogen bonds) is listed. Hydrogen bonds  All interactions   1  H41, C145, E166, V186  L27, S46, L50, Y54,L167, T169, V186  2  L141, N142, G143,H164, Q189, T190  T25, F140, L141,H172, A191  3  R188, Q192  T26, H163, Q192  4  S144  M49, S144, P168, T190  5  -N142,D187  6  -G143, H164  7  -H41, E166  8  -C145, Covid-19 patients, independent of patient age and comorbidi-594 ties [18] . (Table S1) ). The production runs of 702 20 ns or 100 ns lengths used the same settings as the NpT equi-703 libration runs. Electrostatic interactions were processed with 704 the particle-mesh Ewald method [36, 37] in combination with 705 periodic boundary conditions and a real-space cutoff of 12 Å.

The Lennard-Jones (LJ) interactions were also cut at 12 Å. To quantify the strength of the 3CL pro -ligand interactions, their interaction energy int = Coul + LJ consisting of Coulomb and LJ contributions was determined, which was accomplished by rerunning the simulation using gmx mdrun -rerun to obtain the energies, which were processed using gmx energy to calculate Coul and LJ between the ligand and the catalytic dyad residues H41 and C145. For the 35 best ligands identified in silico, we also computed the binding free energy Δ bind using the MM/PBSA method as implemented in g_mmpbsa (https://rashmikumari.github. io/g_mmpbsa/) [16] . This analysis was applied to 626 MD snapshots sampled every 40 ps between 75 ns and 100 ns of the MD simulations. Within the MM/PBSA scheme the binding free energy is defined as

where ⟨⋅⟩ indicates the average over the 626 snapshots in the current case. The free energy for each of these three entities is given as

where bonded describes the bonded interactions, which is like Coul and LJ obtained from the force field, polar and 739 nonpolar are the polar and nonpolar contributions to the solva-740 tion free energy, and the last term is the absolute temperature, 

The inhibitory potential against the SARS-CoV-2 3CL pro 836 activity of the best compounds identified in the virtual screen-837 ing was investigated using the activity assay described above.

The mixtures were incubated for 30 min at RT. When the

Spike protein recognition of mam-867 malian ace2 predicts the host range and an optimized ace2 for sars-868 cov-2 infection

Cryo-em structure of the 2019-ncov spike in 871 the prefusion conformation

Fusion mechanism of 2019-ncov and fusion inhibitors 874 targeting hr1 domain in spike protein

Sars-877 cov-2 cell entry depends on ace2 and tmprss2 and is blocked by a 878 clinically proven protease inhibitor

A struc-880 tural view of sars-cov-2 rna replication machinery: Rna synthesis, 881 proofreading and final capping

High throughput virtual screening to discover inhibitors of the main 884 protease of the coronavirus sars-cov-2

Ensemble Docking in Drug Discovery

Gender differences in patients with covid-19: Focus on severity 890 and mortality, Front. in Public Health

Structure 895 of M pro from COVID-19 virus and discovery of its inhibitors

Synthe-901 sis, and Activity Assessment

Bridging Molecular Docking to Molecular 903 Dynamics in Exploring Ligand-Protein Recognition Process: An 904

LIGPLOT: a program to 906 generate schematic diagrams of protein-ligand interactions

LigPlot+: Multiple Ligand-Protein 909

Interaction Diagrams for Drug Discovery

Triple combination of interferon 917 beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients 918 admitted to hospital with COVID-19: an open-label, randomised, 919 phase 2 trial

A novel syk kinase inhibitor suitable for inhalation: R-921 343(?) -wo-2009031011

Inhibition of SARS-CoV 3CL 927 protease by flavonoids

Screening for low testosterone is 930 needed for early identification and treatment of men at high risk of 931 mortality from covid-19

Coronavirus susceptibility to the antiviral remdesivir (gs-5734) is me-936 diated by the viral polymerase and the proofreading exoribonuclease

Template-dependent inhibition of 940 coronavirus rna-dependent rna polymerase by remdesivir reveals a 941 second mechanism of action

Development and 943 testing of a general amber force field

Cheese-946 man

A well-behaved elec-960 trostatic potential based method using charge restraints for deriving 961 atomic charges: the RESP model

charges to calculate conformational energies, hydrogen bond energies, 965 and free energies of solvation

Automatic atom type and 967 bond type perception in molecular mechanical calculations

ACPYPE -AnteChamber PYthon 981 Parser interfacE

Lin-983 dahl, GROMACS: High performance molecular simulations through 984 multi-level parallelism from laptops to supercomputers

Improving the accuracy of protein side chain 988 and backbone parameters from ff99sb

Parmbsc1: a refined force field for DNA simula-994 tions

Com-996 parison of simple potential functions for simulating liquid water

Méthode généerale pour la résolution des systèmes d' 999 éequations simultanéees

Molecular-Dynamics Method for Simulations in the Canoni-1001 cal Ensemble

Canonical Dynamics -Equilibrium Phase-Space Distribu-1003 tions

Polymorphic Transitions in Single-Crystals 1005 -a New Molecular-Dynamics Method

Particle Mesh Ewald -an N.Log(N)

Method for Ewald Sums in Large Systems

A Smooth Particle Mesh Ewald 1011

LINCS: A linear con-1013 straint solver for molecular simulations

The PyMOL Molecular Graphics System, Version 1

When Simulation Meets Experiment

Python 3 Reference Manual

Crystal structure of SARS-CoV-2 1026 main protease provides a basis for design of improved -ketoamide 1027 inhibitors

gc-376, and calpain inhibitors ii, xii inhibit sars-cov-2 viral replication 1031 by targeting the viral main protease, bioRxiv : the preprint server for 1032 biology

JURECA: Modular supercomputer at Jülich 1034

x The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: